| NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
| NCT02201563 | Irradiation; Adverse Effect | Drug: Minocycline | University of Pittsburgh | Phase 1 | 2015-11-01 | 2015-12-23 |
| NCT01514422 | Bipolar Depression | Drug: Minocycline | Icahn School of Medicine at Mount Sinai | Phase 4 | 2011-05-01 | 2016-12-06 |
| NCT01493622 | Schizophrenia | Drug: minocycline|Drug: placebo | Central South University | Phase 4 | 2010-06-01 | 2011-12-14 |
| NCT01429272 | Bipolar Disorder Depression | Drug: Minocycline|Drug: Aspirin|Drug: placebo | Laureate Institute for Brain Research, Inc.|Stanley Medical Research Institute|University of Oklahoma | Phase 3 | 2011-09-01 | 2015-10-28 |
| NCT00666887 | Clinically Isolated Syndromes|Early Single Relapse of Multiple Sclerosis | Drug: Minocycline|Drug: Placebo | Dr. Luanne Metz|Multiple Sclerosis Society of Canada|University of Calgary | Phase 3 | 2009-01-01 | 2017-02-23 |
| NCT01805895 | Intracerebral Hemorrhage | Drug: Minocycline | Augusta University|American Heart Association | Phase 1|Phase 2 | 2013-02-01 | 2016-02-09 |
| NCT02312609 | Healthy | Drug: Minocycline hydrochloride | Ranbaxy Laboratories Limited|Ranbaxy Inc. | | 2008-09-01 | 2014-12-08 |
| NCT02312297 | Healthy | Drug: Minocycline hydrochloride | Ranbaxy Laboratories Limited|Ranbaxy Inc. | | 2008-09-01 | 2014-12-08 |
| NCT02178813 | Stroke | Drug: Administration of minocycline | University of Pittsburgh | Phase 1 | 2014-07-01 | 2016-07-27 |
| NCT01561742 | Schizophrenia | Drug: Minocycline|Drug: Placebo | The University of Texas Health Science Center, Houston|Stanley Medical Research Institute | | 2012-02-01 | 2012-03-22 |
| NCT00418392 | Pneumothorax | Procedure: Simple aspiration with minocycline pleurodesis|Procedure: simple aspiration | National Taiwan University Hospital | Phase 3 | 2006-11-01 | 2012-12-13 |
| NCT00668746 | Periodontitis | Drug: Minocycline HCl microspheres | OraPharma | Phase 4 | 2007-12-01 | 2011-12-06 |
| NCT01403662 | Bipolar Disorder|Bipolar Depression|Bipolar I Depression|Bipolar II Depression | Drug: Minocycline | University Health Network, Toronto | Phase 3 | 2011-07-01 | 2016-12-15 |
| NCT01779089 | Diabetic Nephropathy | Drug: Minocycline 100 mg po bid for 6 months|Drug: placebo | Los Angeles Biomedical Research Institute | | 2009-02-01 | 2015-05-20 |
| NCT00240513 | Acne Vulgaris | Drug: Minocycline|Drug: Minocycline plus tretinoin | Derm Research @ 888 Inc.|Stiefel, a GSK Company | Phase 4 | 2004-08-01 | 2012-02-22 |
| NCT02140164 | Retinitis Pigmentosa | Drug: Minocycline | National Eye Institute (NEI)|The EMMES Corporation|National Institutes of Health Clinical Center (CC) | Phase 1|Phase 2 | 2014-05-01 | 2016-11-18 |
| NCT03050086 | Moderate to Severe Papulopustular Rosacea | Drug: 1% minocycline topical gel | BioPharmX, Inc. | Phase 1|Phase 2 | 2017-03-01 | 2017-02-08 |
| NCT01422148 | Atrial Fibrillation | Drug: Amiodarone|Drug: Minocycline | Baystate Medical Center | | 2011-10-01 | 2017-01-30 |
| NCT02541500 | Heroin Dependence|Amphetamine Dependence | Drug: Minocycline | University of Science Malaysia|Yale University | Phase 3 | 2013-04-01 | 2015-09-01 |
| NCT02695446 | Acne | Drug: Minocycline | BioPharmX, Inc. | Phase 4 | 2016-03-01 | 2016-05-14 |
| NCT01053156 | Fragile X Syndrome | Drug: minocycline hydrochloride|Drug: Placebo | University of California, Davis|The National Fragile X Foundation | | 2010-01-01 | 2014-06-30 |
